Home / Lanreotide / Australia
AU ATC H01CB03 · updated 2 Nov 2026
Lanreotide shortage in Australia
Is there a Lanreotide shortage in Australia?
Yes. As of 2 Nov 2026, 3 Lanreotide products are reported short in Australia, the first since 29 Nov 2024. The company estimate for the return is 31 Dec 2026. Main reason: not stated.
Also short in Germany, Italy, Spain, Austria, Norway. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe | 29 Nov 2024 | 31 Dec 2026 | Not stated | |
| AU | MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe | 12 Dec 2025 | 31 Dec 2026 | Not stated | |
| AU | MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe | 29 Jun 2026 | 31 Dec 2026 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.